248 related articles for article (PubMed ID: 32736549)
21. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
22. Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters.
Akkan T; Altay M; Ünsal Y; Dağdeviren M; Beyan E
Endocrine; 2017 Dec; 58(3):513-520. PubMed ID: 29043559
[TBL] [Abstract][Full Text] [Related]
23. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
[TBL] [Abstract][Full Text] [Related]
24. Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: A review.
Araujo-Castro M
Clin Endocrinol (Oxf); 2022 Dec; 97(6):693-701. PubMed ID: 35451056
[TBL] [Abstract][Full Text] [Related]
25. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
26. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
Imga NN; Topcuoglu C; Berker D; Turhan T
Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
[TBL] [Abstract][Full Text] [Related]
27. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
Araujo-Castro M; Pascual-Corrales E; Lamas C
Ann Endocrinol (Paris); 2023 Apr; 84(2):272-284. PubMed ID: 36736771
[TBL] [Abstract][Full Text] [Related]
28. Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis.
Tuna MM; Imga NN; Doğan BA; Yılmaz FM; Topçuoğlu C; Akbaba G; Berker D; Güler S
J Endocrinol Invest; 2014 Aug; 37(8):765-768. PubMed ID: 24923898
[TBL] [Abstract][Full Text] [Related]
29. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma.
Papanastasiou L; Pappa T; Samara C; Apostolopoulou G; Tsiavos V; Markou A; Alexandraki K; Piaditis G; Chrousos G; Kaltsas G
Eur J Clin Invest; 2012 Nov; 42(11):1165-72. PubMed ID: 23078137
[TBL] [Abstract][Full Text] [Related]
31. Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma.
Yener S; Genc S; Akinci B; Secil M; Demir T; Comlekci A; Ertilav S; Yesil S
Endocrine; 2009 Jun; 35(3):365-70. PubMed ID: 19277910
[TBL] [Abstract][Full Text] [Related]
32. Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.
Kelsall A; Iqbal A; Newell-Price J
Gland Surg; 2020 Feb; 9(1):94-104. PubMed ID: 32206602
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.
Di Dalmazi G; Vicennati V; Pizzi C; Mosconi C; Tucci L; Balacchi C; Cosentino ER; Paolisso P; Fanelli F; Gambineri A; Pelusi C; Repaci A; Garelli S; Galiè N; Borghi C; Golfieri R; Pagotto U
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413902
[TBL] [Abstract][Full Text] [Related]
34. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
[TBL] [Abstract][Full Text] [Related]
35. Frequency of masked hypertension in patients with nonfunctioning adrenal incidentalomas with normal and high normal blood pressure.
Yılmaz F; Sözel H; Keleş M; Yılmaz Ü
Ir J Med Sci; 2022 Aug; 191(4):1631-1638. PubMed ID: 34368927
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis.
Sconfienza E; Tetti M; Forestiero V; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2023 Jun; 108(7):1813-1823. PubMed ID: 36718682
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
[TBL] [Abstract][Full Text] [Related]
38. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
Araujo-Castro M; Casals G; Hanzu FA; Pascual-Corrales E; García Cano AM; Lanza VF; Luis Del Rey Mejías Á; Marchan M; Escobar-Morreale HF; Valderrabano P
Clin Endocrinol (Oxf); 2023 Feb; 98(2):165-176. PubMed ID: 35973974
[TBL] [Abstract][Full Text] [Related]
40. Pancreatosteatosis in patients with adrenal incidentaloma: A risk factor for impaired glucose metabolism.
Candemir B; Kisip K; Akın Ş; Tuba Sanal H; Taşar M; Altunkaynak B; Ersöz Gülçelik N
Diabetes Res Clin Pract; 2024 Feb; 208():111099. PubMed ID: 38246510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
